Max Healthcare Institute Ltd.

In furtherance to its letter dated February 04, 2022 regarding intimation of investor / analysts’ meet scheduled to be held from February 07, 2022 to February 11, 2022, in terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Max Healthcare Institute has informed that the Management’s interaction with the various investors as per the schedule is attached. No unpublished price sensitive information shall be shared / discussed at the investors / analysts’ meet.

The above information is a part of company’s filings submitted to BSE.